Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.9K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

8.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.8K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

10.1K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Pretreatment blocking of intrapericardial pulmonary artery in operation of lung cancer invading pulmonary artery].

Zhongguo fei ai za zhi = Chinese journal of lung cancer·2010
Same author

Pentagalloylglucose downregulates cofilin1 and inhibits HSV-1 infection.

Antiviral research·2010
Same author

Neuronal calcium sensor synaptotagmin-9 is not involved in the regulation of glucose homeostasis or insulin secretion.

PloS one·2010
Same author

Processing bodies and plant development.

Current opinion in plant biology·2010
Same author

Ammonium, microcystins, and hypoxia of blooms in eutrophic water cause oxidative stress and C-N imbalance in submersed and floating-leaved aquatic plants in Lake Taihu, China.

Chemosphere·2010
Same author

Enhancement of chlorophenol sorption on soil by geophagous earthworms (Metaphire guillelmi).

Chemosphere·2010

Related Experiment Video

Updated: Mar 1, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.1K

MAPK/P53-mediated FASN expression in bone tumors.

Ye Jiang1, Xiaofan Yin1, Liang Wu1

  • 1Department of Orthopaedics, Minhang Hospital, Fudan University, Shanghai 201199, P.R. China.

Oncology Letters
|June 8, 2017
PubMed
Summary

Mitogen-activated protein kinase (MAPK)/P53 signaling drives fatty acid synthase (FASN) expression, promoting bone tumor growth. Inhibiting this pathway reduces FASN and bone cancer cell proliferation.

Keywords:
bone tumorfatty acid synthasemitogen-activated protein kinase/P53regulationsignal pathway

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.2K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

862

Related Experiment Videos

Last Updated: Mar 1, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.1K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.2K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

862

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Fatty acid synthase (FASN) is implicated in various cancers.
  • The role of MAPK/P53 signaling in bone tumor development requires further elucidation.

Purpose of the Study:

  • To investigate the correlation between MAPK/P53 signaling, FASN expression, and bone tumor progression.
  • To determine the therapeutic potential of targeting the MAPK/P53 pathway in bone cancer.

Main Methods:

  • Established the SH081 bone tumor cell line for experimental analysis.
  • Quantified mRNA and protein levels of FASN and MAPK/P53 in tumor and normal cells.
  • Utilized MAPK/P53 inhibitors to assess effects on FASN expression and cell proliferation.

Main Results:

  • Significantly elevated MAPK/P53 and FASN mRNA and protein levels were observed in bone tumor cells compared to normal cells.
  • Inhibition of MAPK/P53 signaling led to decreased FASN expression.
  • Treatment with a MAPK/P53 inhibitor reduced the proliferation rate of bone cancer cells.

Conclusions:

  • FASN plays a crucial role in promoting bone tumor development.
  • MAPK/P53 signaling contributes to bone tumorigenesis by upregulating FASN expression.
  • Targeting the MAPK/P53/FASN axis presents a potential therapeutic strategy for bone cancer.